Predicting Benign Prostate Pathology on Magnetic Resonance Imaging/Ultrasound Fusion Biopsy in Men with a Prior Negative 12-core Systematic Biopsy: External Validation of a Prognostic Nomogram

Marc A. Bjurlin, Audrey Renson, Soroush Rais-Bahrami, Matthew Truong, Andrew B. Rosenkrantz, Richard Huang, Samir S. Taneja

    Research output: Contribution to journalArticlepeer-review

    Abstract

    We externally validated a clinically useful tool that predicts benign prostate pathology on magnetic resonance imaging/ultrasound fusion–targeted biopsy in men with a prior negative 12-core systematic biopsy and updated this predictive tool to improve its performance in patient counseling regarding the need for a repeat biopsy.

    Original languageEnglish (US)
    Pages (from-to)815-822
    Number of pages8
    JournalEuropean Urology Focus
    Volume5
    Issue number5
    DOIs
    StatePublished - Sep 2019

    Keywords

    • Benign
    • External validation
    • Magnetic resonance imaging/ultrasound fusion–targeted prostate biopsy
    • Nomogram
    • Prior negative biopsy
    • Prostate cancer

    ASJC Scopus subject areas

    • Urology

    Fingerprint Dive into the research topics of 'Predicting Benign Prostate Pathology on Magnetic Resonance Imaging/Ultrasound Fusion Biopsy in Men with a Prior Negative 12-core Systematic Biopsy: External Validation of a Prognostic Nomogram'. Together they form a unique fingerprint.

    Cite this